Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.007
Neutral
RSI(14)
49.074
Neutral
STOCH(KDJ)(9,3,3)
38.966
Sell
ATR(14)
0.354
High Vlolatility
CCI(14)
-15.677
Neutral
Williams %R
60.492
Sell
TRIX(12,20)
0.122
Sell
StochRSI(14)
0.000
Oversold
Kenvue Inc
KVUE17.200USD
-0.140-0.81%
Close 01/29, 16:00（ET）Quotes delayed by 15 min
32.95BMarket Cap
23.00P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Kenvue Inc
Currency: USD Updated: 2026-01-29Key Insights
Kenvue Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 23 out of 36 in the Personal & Household Products & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 19.55.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Kenvue Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Kenvue Inc Highlights
StrengthsRisks
Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 150.68%.
Fairly Valued
The company’s latest PE is 23.00, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.89B shares, decreasing 14.96% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 42.02K shares of this stock.
Analyst Rating
Based on
15
analysts
Hold
Current Rating
19.547
Target Price
+11.70%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-01-29The current financial score of Kenvue Inc is 7.35, ranking 20 out of 36 in the Personal & Household Products & Services industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 3.76B, representing a year-over-year decrease of 3.46%, while its net profit experienced a year-over-year decrease of 3.92%.
Score
Financials
7.46
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.34
Operational Efficiency
7.29
Growth Potential
7.40
Shareholder Returns
7.23
Kenvue Inc's Company Valuation
Currency: USD Updated: 2026-01-29The current valuation score of Kenvue Inc is 4.89, ranking 34 out of 36 in the Personal & Household Products & Services industry. Its current P/E ratio is 23.00, which is 93.32% below the recent high of 44.47 and 21.32% above the recent low of 18.10.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 23/36
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-01-29The current earnings forecast score of Kenvue Inc is 6.27, ranking 23 out of 36 in the Personal & Household Products & Services industry. The average price target is 19.00, with a high of 24.11 and a low of 17.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
15
analysts
Hold
Current Rating
19.547
Target Price
+11.70%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
16
Total
10
Median
12
Average
Company name
Ratings
Analysts
Kenvue Inc
KVUE
15
Estee Lauder Companies Inc
EL
27
Procter & Gamble Co
PG
27
Colgate-Palmolive Co
CL
22
Coty Inc
COTY
18
Kimberly-Clark Corp
KMB
17
1
2
3
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-01-29The current price momentum score of Kenvue Inc is 6.56, ranking 27 out of 36 in the Personal & Household Products & Services industry. Currently, the stock price is trading between the resistance level at 17.87 and the support level at 16.54, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
17.496
Sell
MA10
17.466
Sell
MA20
17.224
Sell
MA50
17.074
Buy
MA100
16.745
Buy
MA200
19.438
Sell
Institutional Confidence
Currency: USD Updated: 2026-01-29The current institutional shareholding score of Kenvue Inc is 10.00, ranking 1 out of 36 in the Personal & Household Products & Services industry. The latest institutional shareholding proportion is 98.65%, representing a quarter-over-quarter decrease of 2.24%. The largest institutional shareholder is The Vanguard, holding a total of 232.47M shares, representing 12.13% of shares outstanding, with 2.03% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
State Street Investment Management (US)
BlackRock Institutional Trust Company, N.A.
Fidelity Management & Research Company LLC
MFS Investment Management
Geode Capital Management, L.L.C.
American Century Investment Management, Inc.
Wellington Management Company, LLP
Independent Franchise Partners LLP
1
2
Risk Assessment
Currency: USD Updated: 2026-01-29The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Personal & Household Products & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Kenvue Inc is 6.84, ranking 18 out of 36 in the Personal & Household Products & Services industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
--
VaR
--
240-Day Maximum Drawdown
+42.27%
240-Day Volatility
+38.43%
Return
Best Daily Return
60 days
+12.32%
120 days
+12.32%
5 years
--
Worst Daily Return
60 days
-2.89%
120 days
-13.22%
5 years
--
Sharpe Ratio
60 days
+2.73
120 days
-0.92
5 years
--
Risk Assessment
Maximum Drawdown
240 days
+42.27%
3 years
--
5 years
--
Return-to-Drawdown Ratio
240 days
-0.41
3 years
--
5 years
--
Skewness
240 days
-0.48
3 years
--
5 years
--
Volatility
Realised Volatility
240 days
+38.43%
5 years
--
Standardised True Range
240 days
+3.23%
5 years
--
Downside Risk-Adjusted Return
120 days
-109.90%
240 days
-109.90%
Maximum Daily Upside Volatility
60 days
+40.57%
Maximum Daily Downside Volatility
60 days
+29.98%
Liquidity
Average Turnover Rate
60 days
+0.95%
120 days
+0.95%
5 years
--
Turnover Deviation
20 days
-5.82%
60 days
+1.72%
120 days
+1.43%
Peer Comparison
Personal & Household Products & Services
Kenvue Inc
KVUE
6.82 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Valvoline Inc
VVV
8.28 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Church & Dwight Co Inc
CHD
8.23 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Service Corporation International
SCI
8.21 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Procter & Gamble Co
PG
7.97 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
WD-40 Co
WDFC
7.94 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
